Tristel PLC
29 August 2006
For release
29 August 2006
Tristel Plc
Technology Acquisition
Agreement with IVC Limited, New Zealand
Tristel plc ('Tristel'), the chlorine dioxide specialist that supplies infection
and contamination control products to healthcare and institutional
establishments and the pharmaceutical and food processing industries, announces
that it has entered into a technology acquisition agreement with IVC Limited,
('IVC'). IVC is Tristel's New Zealand distributor and its principal shareholder
is Mark Fraundorfer, an internationally renowned Urologist.
Under the terms of the agreement IVC transfers to Tristel the design and patent
rights to two inventions which it has created to work specifically with
Tristel's chlorine dioxide chemistry. The inventions are a sterilizing tray
system which enables single use decontamination of endoscopic equipment and a
hygiene work station which enables Tristel's highly effective sporicidal
chemistry to be easily applied to floors and walls in high risk wards and
departments of hospitals.
IVC has funded the design and development process to date and transfers the
intellectual property created in return for unspecified future royalties.
Commenting upon the agreement, Paul Swinney, Chief Executive of Tristel, said:
'Outside of the most advanced healthcare markets, where endoscopes are mainly
processed in sophisticated and costly automated machines, the majority of
endoscopes are disinfected in basic trays and sinks. These can only hold
disinfectant liquids that have to be used repeatedly for many instruments over a
period of many hours or even days.
'The Tristel tray system, combined with Tristel's novel burstable sachet,
Tristel Fusion, enables the disinfectant to be used once and to be dedicated to
one instrument only.
'This achieves one of the key features of the most sophisticated endoscope
reprocessing machines at a fraction of their cost, and will help Tristel
penetrate many overseas markets with its chlorine dioxide disinfectants.'
Tristel plc Parkgreen Communications Ltd
Paul Swinney, Chief Executive Paul McManus
Paul Barnes, Finance Director Tel 020 7493 3716
Tel: 01638 721 500 Mob: 07980 541 893
http://www.tristel.com paul.mcmanus@parkgreenmedia.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.